Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03231995Completed
Single-arm trial, sponsored by Hospices Civils de Lyon. Primary endpoint: Definition and evaluation of a microbial signature discriminating patients developing severe influenza from those developing moderate influenza at Day 30. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03231995.